dextroamphetamine 18 MG in 9 HR Transdermal System
- RxCUI
- 2624712
- RxNorm name
- dextroamphetamine 18 MG in 9 HR Transdermal System
- Display name
- dextroamphetamine 18 MG in 9 HR Transdermal System
- Full name
- dextroamphetamine 18 MG in 9 HR Transdermal System
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:46
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| XELSTRYM | DEXTROAMPHETAMINE | Noven Therapeutics, LLC | 0862f02a-72a8-41cc-8845-57cf4974bb6f | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | 2624712 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 0862f02a-72a8-41cc-8845-57cf4974bb6f | dextroamphetamine 18 MG in 9 HR Transdermal System | PSN | 17 | These highlights do not include all the information needed to use XELSTRYM safely and effectively. See full prescribing information for XELSTRYM. XELSTRYM ® (dextroamphetamine) transdermal system, CII Initial U.S. Approval: 1975 | 20251223 |
| 0862f02a-72a8-41cc-8845-57cf4974bb6f | 9 HR dextroamphetamine 2 MG/HR Transdermal System | SCD | 17 | These highlights do not include all the information needed to use XELSTRYM safely and effectively. See full prescribing information for XELSTRYM. XELSTRYM ® (dextroamphetamine) transdermal system, CII Initial U.S. Approval: 1975 | 20251223 |
| 0862f02a-72a8-41cc-8845-57cf4974bb6f | dextroamphetamine 18 MG per 9 HR Transdermal System | SY | 17 | These highlights do not include all the information needed to use XELSTRYM safely and effectively. See full prescribing information for XELSTRYM. XELSTRYM ® (dextroamphetamine) transdermal system, CII Initial U.S. Approval: 1975 | 20251223 |